These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25119803)

  • 1. Relationships between pharmacokinetic parameters of carbamazepine and therapeutic response in patients with bipolar disease.
    Chbili C; Bannour S; Khlifi S; Ben Hadj Ali B; Saguem S
    Ann Biol Clin (Paris); 2014; 72(4):453-9. PubMed ID: 25119803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamazepine and its 10,11-epoxide metabolite in acute mania: clinical and pharmacokinetic correlates.
    Petit P; Lonjon R; Cociglio M; Sluzewska A; Blayac JP; Hue B; Alric R; Pouget R
    Eur J Clin Pharmacol; 1991; 41(6):541-6. PubMed ID: 1815966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How long does the pharmacokinetic interaction between carbamazepine and quetiapine last after carbamazepine withdrawal?
    Kopecek M; Potmesil P
    Neuro Endocrinol Lett; 2017 Dec; 38(7):475-478. PubMed ID: 29369597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Historical review of carbamazepine for the treatment of bipolar disorder.
    Stoner SC; Nelson LA; Lea JW; Marken PA; Sommi RW; Dahmen MM
    Pharmacotherapy; 2007 Jan; 27(1):68-88. PubMed ID: 17192163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of atypical manias with finlepsin-retard].
    Dziub HK; Chuprykov AP; Harnyts'ka AS; Protsyk VO; Os'kina VM; Benes'ko OI
    Lik Sprava; 1996; (1-2):146-8. PubMed ID: 9005078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring plasma levels of carbamazepine. A pharmacokinetic study in patients with affective disorders.
    Nolen WA; Jansen GS; Broekman M
    Pharmacopsychiatry; 1988 Sep; 21(5):252-4. PubMed ID: 3227056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
    Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
    J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response.
    Post RM; Uhde TW; Ballenger JC; Chatterji DC; Greene RF; Bunney WE
    Arch Gen Psychiatry; 1983 Jun; 40(6):673-6. PubMed ID: 6847334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bipolar depression with carbamazepine: results of an open study.
    Dilsaver SC; Swann SC; Chen YW; Shoaib A; Joe B; Krajewski KJ; Gruber N; Tsai Y
    Biol Psychiatry; 1996 Nov; 40(9):935-7. PubMed ID: 8896785
    [No Abstract]   [Full Text] [Related]  

  • 10. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine versus lithium in mania: a double-blind study.
    Lerer B; Moore N; Meyendorff E; Cho SR; Gershon S
    J Clin Psychiatry; 1987 Mar; 48(3):89-93. PubMed ID: 3546274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder.
    Greil W; Kleindienst N
    Int Clin Psychopharmacol; 1999 Sep; 14(5):277-81. PubMed ID: 10529070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing simultaneous concentrations of carbamazepine and its epoxide in plasma.
    McKauge L; Tyrer JH; Eadie MJ
    Ther Drug Monit; 1981; 3(1):63-70. PubMed ID: 7233491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between pharmacokinetic parameters of carbamazepine and therapeutic response in epileptic patients.
    Chbili C; Hassine A; Laouani A; Amor SB; Nouira M; Ammou SB; Saguem S
    Arch Med Sci; 2017 Mar; 13(2):353-360. PubMed ID: 28261288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamazepine decreases antihypertensive effect of nilvadipine.
    Yasui-Furukori N; Tateishi T
    J Clin Pharmacol; 2002 Jan; 42(1):100-3. PubMed ID: 11808819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():9-14. PubMed ID: 16754406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy.
    Eichelbaum M; Bertilsson L; Lund L; Palmér L; Sjöqvist F
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):417-21. PubMed ID: 971704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
    Zhang ZJ; Kang WH; Li Q; Tan QR
    J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144).
    Nolen WA; Weisler RH
    Bipolar Disord; 2013 Feb; 15(1):100-9. PubMed ID: 23228201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.